Guardant Health (GH, $18) was a top loser over the last three months, falling -1 to $18 per share. A.I.dvisor analyzed 460 stocks in the Medical Specialties Industry for the 3-month period ending April 30, 2024, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend.